- NEUTRAL
Quarterly Revenue Genprex Inc Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.
- POSITIVE
Quarterly Net Profit Genprex Inc Jun-2026 Quarterly Net Profit is $-4 Million which is growth of 4.9% YoY.
2.620.01(0.38%)
199.4K
XNAS Volume
XNAS 07 Oct, 2026 5:30 PM (EDT)
Genprex Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Genprex Inc quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Rev. | ||||||||||||||
Cost Of Rev. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 4.5 | 4.5 | 3.5 | 3.4 | 4.7 | 4 | 4.3 | 4.3 | 6.5 | 6 | 6 | 7.8 | 8 | ||
Operating Profit | -4.5 | -4.5 | -3.5 | -3.4 | -4.7 | -4 | -4.3 | -4.3 | -6.5 | -6 | -6 | -7.8 | -8 | |
| - | 0 | -0.3 | -0.5 | - | 0 | 0 | 0 | 0 | 0.1 | 0.1 | ||||
Profit Before Tax | -4.5 | -4.5 | -3.8 | -3.8 | -4.7 | -4 | -4.3 | -4.3 | -6.5 | -6 | -5.9 | -7.8 | -8 | |
Tax | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| -4.5 | -4.5 | -3.8 | -3.8 | -4.7 | -4 | -4.3 | -4.3 | -6.5 | -6 | -5.9 | -7.8 | -8 | ||
Diluted NI Avail to Com Stockholders Ann. | -4.5 | -4.5 | -3.8 | -3.8 | -4.7 | -4 | -4.3 | -4.3 | -6.5 | -6 | -5.9 | -7.8 | -8 | |
Basic EPS | -9.4 | -14.1 | -25.3 | -110 | -187 | -286 | -438.6 | -1,353 | -3,300 | -4,059 | -4,136 | -5,720 | -6,600 | |
Diluted EPS After ExtraOrdinary | -9.4 | -14.1 | -25.3 | -110 | -187 | -286 | -438.6 | -1,353 | -3,300 | -4,059 | -4,136 | -5,720 | -6,600 | |
Number Of Shares End | 0.5 | 0.3 | 0.2 | 0 | 0 | 0 | 0 | |||||||
Net Income Continuing Discontinued Operations | -4.5 | -4.5 | -3.8 | -3.8 | -4.7 | -4 | -4.3 | -4.3 | -6.5 | -6 | -5.9 | -7.8 | -8 | |
Normalized Income | -4.5 | -4.5 | -3.8 | -3.8 | -4.7 | -4 | -4.3 | -4.3 | -6.5 | -6 | -5.9 | -7.8 | -8 | |
Interest Income | - | 0 | - | - | - | 0 | 0 | 0 | 0 | 0.1 | 0.1 | |||
Interest | - | - | 0.3 | 0.5 | - | - | - | - | - | - | - | - | - | |
Net Interest Income | - | 0 | -0.3 | -0.5 | - | 0 | 0 | 0 | 0 | 0.1 | 0.1 | |||
EBIT | -4.5 | -4.5 | -3.5 | -3.3 | -4.7 | -4 | -4.3 | -4.3 | -6.5 | -6 | -6 | -7.8 | -8 | |
EBITDA | -4.5 | -4.5 | -3.5 | -3.3 | -4.7 | -4 | -4.3 | -4.3 | -6.5 | -6 | -6 | -7.8 | -8 | |
Reconciled Cost Of Rev. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Reconciled Depr. | - | |||||||||||||
Profit From Continuing Operations | -4.5 | -4.5 | -3.8 | -3.8 | -4.7 | -4 | -4.3 | -4.3 | -6.5 | -6 | -5.9 | -7.8 | -8 | |
Normalized EBITDA | -4.5 | -4.5 | -3.5 | -3.3 | -4.7 | -4 | -4.3 | -4.3 | -6.5 | -6 | -6 | -7.8 | -8 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Genprex Inc competitor comparison and performance snapshot within industry
Genprex Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEUTRAL
Annual Revenue Genprex Inc Annual Revenue is $0 Million which is growth of 0% YoY.
- POSITIVE
Annual Net Profit Genprex Inc Annual Net Profit is $-16 Million which is growth of 23.1% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | TTM | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | ||||||||||||||
Cost Of Rev. Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | ||
Gross Profit Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | ||
Operating Exp. Ann. | -13.3% | -2.9% | 15.8 | 15.5 | 21.2 | 31.1 | 23.8 | 19.6 | 18 | 10.7 | 12.4 | 3.3 | 4.1 | 1.1 | |
Operating Profit Ann. | - | - | -15.8 | -15.5 | -21.2 | -31.1 | -23.8 | -19.6 | -18 | -10.7 | -12.4 | -3.3 | -4.1 | -1.1 | |
- | - | -0.7 | 0.1 | 0.2 | 0.1 | 0 | 0 | 0 | -0 | - | - | ||||
Other Exp. Ann. | - | - | 0 | - | - | - | - | - | - | - | - | - | |||
PBT Ann. | - | - | -16.5 | -16.2 | -21.1 | -30.9 | -23.7 | -19.6 | -17.9 | -10.7 | -12.4 | -3.3 | -4.1 | -1.1 | |
Tax Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | ||
- | - | -16.5 | -16.2 | -21.1 | -30.9 | -23.7 | -19.6 | -17.9 | -10.7 | -12.4 | -3.3 | -4.1 | -1.1 | ||
Diluted NI Avail to Com Stockholders Ann. | - | - | -16.5 | -16.2 | -21.1 | -30.9 | -23.7 | -19.6 | -17.9 | -10.7 | -12.4 | -3.3 | -4.1 | -1.1 | |
EPS Ann. | - | - | -382.8 | -5,874 | -24,816 | -22,000 | -18,480 | -18,327.7 | -24,381.6 | -35,758.2 | -11,196.5 | -13,960 | -3,613.9 | ||
Diluted EPS Ann. | - | - | -382.8 | -5,874 | -24,816 | -22,000 | -18,480 | -18,327.7 | -24,381.6 | -35,758.2 | -11,196.5 | -13,960 | -3,613.9 | ||
Number Of Shares End | - | - | 0.2 | 0 | - | ||||||||||
Total Exp. Ann. | -13.3% | -2.9% | 15.5 | 21.2 | 31.1 | 23.8 | 19.6 | 18 | 10.7 | 12.4 | 3.3 | 4.1 | 1.1 | ||
Net Income Continuing Discontinued Operations Ann. | - | - | -16.5 | -16.2 | -21.1 | -30.9 | -23.7 | -19.6 | -17.9 | -10.7 | -12.4 | -3.3 | -4.1 | -1.1 | |
Normalized Income Ann. | - | - | -16.5 | -16.2 | -21.1 | -30.9 | -23.7 | -19.6 | -17.9 | -10.7 | -12.4 | -3.3 | -4.1 | -1.1 | |
Interest Income Ann. | - | - | - | 0.1 | 0.2 | 0.1 | 0 | 0 | 0 | 0 | - | - | |||
Interest Ann. | - | - | 0.7 | - | - | - | - | - | 0 | - | - | ||||
EBITDA Ann. | - | - | -15.8 | -15.5 | -21.2 | -31.1 | -23.8 | -19.6 | -17.9 | -10.6 | -12.3 | -3.3 | -4.1 | -1.1 | |
Reconciled Cost Of Rev. Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | ||
Reconciled Depr. Ann. | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Profit From Continuing Operations Ann. | - | - | -16.5 | -16.2 | -21.1 | -30.9 | -23.7 | -19.6 | -17.9 | -10.7 | -12.4 | -3.3 | -4.1 | -1.1 | |
Normalized EBITDA Ann. | - | - | -15.8 | -15.5 | -21.2 | -31.1 | -23.8 | -19.6 | -17.9 | -10.6 | -12.3 | -3.3 | -4.1 | -1.1 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Operating Exp. Ann.
1Y CHG
-26.9%
2Y CAGR
-29.4%
3Y CAGR
-13.3%
5Y CAGR
-2.9%
7Y CAGR
3.2%
10Y CAGR
30.3%
Operating Expenses Annual Cr is falling faster than historical averages.
Genprex Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Genprex Inc Dec-2025 Total Shareholders Fund is $8 Million which is growth of 391.4% YoY.
- POSITIVE
Total Assets Genprex Inc Dec-2025 Total Assets is $10 Million which is growth of 146.3% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-25.9% | -20.1% | 10.2 | 4.1 | 10.7 | 25.1 | 42.9 | 31.4 | 3.5 | 9.3 | 1.3 | 1.9 | 0.4 | ||
-7.7% | 34.5% | 2.2 | 2.5 | 3.3 | 2.8 | 1.6 | 0.5 | 0.5 | 0.4 | 0.8 | 0.3 | 0 | ||
-28.9% | -23.7% | 8 | 1.6 | 7.4 | 22.3 | 41.3 | 30.9 | 3 | 8.9 | 0.4 | 1.6 | 0.4 | ||
Total Capitalization Ann. | -28.9% | -23.7% | 8 | 1.6 | 7.4 | 22.3 | 41.3 | 30.9 | 3 | 8.9 | 0.4 | 1.6 | 0.4 | |
Tangible Assets Ann. | -28.2% | -23.4% | 8 | 1.6 | 6.6 | 21.6 | 40.6 | 30.3 | 2.5 | 8.5 | 0.1 | 1.4 | 0.2 | |
Working Capital Ann. | -30.8% | -27.2% | 6.2 | -0.4 | 4.3 | 18.7 | 37.6 | 30.3 | 2.5 | 8.5 | -0.6 | 1.4 | 0.2 | |
Invested Capital Ann. | -28.9% | -23.7% | 8 | 1.6 | 7.4 | 22.3 | 41.3 | 30.9 | 3 | 8.9 | 0.4 | 1.6 | 0.4 | |
Tangible Book Value Ann. | -28.2% | -23.4% | 8 | 1.6 | 6.6 | 21.6 | 40.6 | 30.3 | 2.5 | 8.5 | 0.1 | 1.4 | 0.2 | |
Borrowings Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Net Debt Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Share Issued Ann. | - | - | 0.2 | 0 | ||||||||||
Number Of Shares End | - | - | 0.2 | 0 | - |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
148.8%
2Y CAGR
-2.4%
3Y CAGR
-25.9%
5Y CAGR
-20.1%
7Y CAGR
1.3%
10Y CAGR
38.2%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
-12%
2Y CAGR
-18.4%
3Y CAGR
-7.7%
5Y CAGR
34.5%
7Y CAGR
27.6%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
400%
2Y CAGR
4%
3Y CAGR
-28.9%
5Y CAGR
-23.7%
7Y CAGR
-1.5%
10Y CAGR
34.9%
Total ShareHolders Funds Annual growth is higher than historical averages.
Genprex Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Book Value Per Share Genprex Inc Book Value Per Share is $18 which is growth of -60.5% YoY.
- NEUTRAL
ROE Genprex Inc ROE is 0% which is growth of 0% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RoA Ann. % | - | - | - | -285.38% | -172.62% | -69.88% | -52.80% | -102.82% | -166.44% | -235.03% | -209.09% | -356.13% | -260.85% | |
ROE Ann. % | - | - | - | -467.24% | -207.88% | -74.71% | -54.29% | -105.73% | -179.00% | -265.79% | -323.01% | -409.95% | -272.58% | |
ROIC % | - | - | - | -263.9 | -60.5 | -27.4 | -13.2 | -19.4 | -74.1 | -35.6 | -102.7 | -61.5 | - | |
OPM Ann. % | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Inventory Turnover Ratio Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Asset Turnover Ann. % | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Working Capital Turnover Ann. | - | - | ||||||||||||
Quick Ratio Ann. | - | - | - | 0.6 | 2.1 | 7.5 | 24.4 | 60.6 | 3.9 | 22.2 | 0.2 | 5.6 | 14.3 | |
Current Ratio Ann. | - | - | - | 0.8 | 2.3 | 7.6 | 24.7 | 68.2 | 5.8 | 22.8 | 0.2 | 5.7 | 15.3 | |
Interest Coverage Ratio Ann. | - | - | - | - | - | - | - | - | - | -324.7 | -1,752.5 | - | - | |
LT Debt To Equity Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Genprex Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Cash From Operating Activity Genprex Inc Cash From Operating Activity is $-15 Million which is growth of 10.7% YoY.
- POSITIVE
Net Cash Flow Genprex Inc Net Cash Flow is $6 Million which is growth of 221.3% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | -15.3 | -17.2 | -24.7 | -17.8 | -14.3 | -13.9 | -6.9 | -6.9 | -2.2 | -1.3 | -0.7 | ||
- | - | -0.1 | 0.1 | -0.1 | -2.3 | -1 | -0.1 | -0.1 | -0.1 | -0 | ||||
- | -12.4% | 21.5 | 12 | 10.6 | 0 | 25.7 | 41.6 | 1.3 | 15.4 | 0.8 | 2.7 | 0.7 | ||
Cash Plus Cash Eqv. End Of Year Ann. | -28.1% | -22.2% | 7.8 | 1.6 | 6.7 | 21 | 38.6 | 27.3 | 2 | 8.6 | 0.2 | 1.6 | 0.2 | |
Net Increase In Cash Plus Cash Eqv.s Ann. | - | -24.5% | 6.2 | -5.1 | -14.2 | -17.7 | 11.3 | 25.3 | -6.6 | 8.4 | -1.4 | 1.4 | 0 | |
Cash Plus Cash Eqv. Begin Of Year Ann. | -65.4% | -4.4% | 1.6 | 6.7 | 21 | 38.6 | 27.3 | 2 | 8.6 | 0.2 | 1.6 | 0.2 | 0.2 | |
Income Tax Paid Supplemental Data Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Interest Paid Supplemental Data Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Capex Ann. | - | - | - | - | -0.1 | -0.1 | -0.1 | -2.3 | -1 | -0.1 | -0.1 | -0.1 | -0 | |
Issuance Of Capital Stock Ann. | - | -12.4% | 21.5 | 12 | 10.6 | 0 | 25.7 | 41.6 | 1.3 | 15.4 | 0.8 | 2.7 | 0.7 | |
Issuance Of Debt Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Repayment Of Debt Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Repurchase Of Capital Stock Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Free Cash Flow Ann. | - | - | -15.3 | -17.2 | -24.8 | -17.8 | -14.4 | -16.3 | -7.9 | -7 | -2.2 | -1.3 | -0.7 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
79.2%
2Y CAGR
42.4%
5Y CAGR
-12.4%
7Y CAGR
4.9%
10Y CAGR
40.8%
Cash from Financing Annual Activity growth is stable compared to historical averages.
